Holdback payments evolved as a way for industry sponsors and CROs to ensure that their clinical research sites were completing the necessary work throughout a trial. However, holdback payments have been a long-standing issue for sites.
Vivienne van de Walle, co-founder of PreCare Trial & Recruitment, shares lessons learned from working with sponsors and CROs to eliminate this practice, and tips for sites to successfully negotiate to have their study costs covered.